Category Archives: Biopsy

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Posted on April 24, 2015 by "Coach" Israel Barken M.D.

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy. Author:  Anthony V. D’Amico Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment

Active Surveillance- Canadian Experience Part 2.

Posted on May 9, 2014 by "Coach" Israel Barken M.D.

  Active Surveillance:  Current status and future direction. Part 2. Mayo Clinic Review, Hawaii Feb 2 2014 Produced by UroToday.      Click here to send me a question by sending a video.  Click to view instructions.

Posted in Active Surveillance, Biopsy, Imaging, PSA, Treatments for Prostate Cancer | Leave a comment

Empiric antibiotics for elevated PSA

Posted on January 4, 2014 by "Coach" Israel Barken M.D.

Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial. Abstract – BJU Int. 2013,Nov;112(7):925-9.  Citation on PubMed Abstract discussed by Dr. Israel Barken , the Medical Director of the Prostate Cancer Research and Education … Continue reading →

Posted in Biopsy, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

MRI detects prostate cancer better than conventional TRUS biopsy, and is implemented through e-communication

Posted on April 3, 2012 by "Coach" Israel Barken M.D.

This is a lecture by Dr. Jelle Barentz. Professor of Radiology Prostate MR-Center of Excellence Department of Radiology Radboud University Nijmegen Medical Centre The Netherlands Topic:  MRI detects prostate cancer better than conventional TRUS biopsy, and is implemented through e-communication. … Continue reading →

Posted in Biopsy, Diagnosis, Imaging, MRI, Prostate Cancer, Treatments for Prostate Cancer | Tagged , | 2 Comments

Question: Shall I do a biopsy of the prostate?

Posted on February 7, 2012 by "Coach" Israel Barken M.D.

The following question is for the Ask Dr Barken Call In Show on Tuesday, Feb. 7th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Question of the week:   An email from a patient gave brief medical history and ended with … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Biopsy, Color Doppler Trans-Rectal Ultrasound, Decision Making, Diagnosis, Imaging, Markers, Prostate Cancer, PSA, Treatments for Prostate Cancer | Leave a comment

Duke Bahn M.D. – Color Doppler Ultrasound: Its Diagnostic Impact on Patient Care

Posted on November 19, 2011 by "Coach" Israel Barken M.D.

Dr. Duke Bahn explains Color Doppler Ultrasound and how is it used for Diagnosis, Biopsy, Active Surveillance and Recurrent Disease, in a presentation at a recent PCRI meeting of radiology experts. Dr. Duke Bahn Phone number: 805-585-3082 or toll free at 888-234-0004. For … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Biopsy, Color Doppler Trans-Rectal Ultrasound, Diagnosis, Focal Therapy, Imaging, PSA, Treatments for Prostate Cancer | Tagged , , , , , , | Leave a comment

MultiParametric MRI and MRI Guided Biopsy

Posted on October 23, 2011 by "Coach" Israel Barken M.D.

Multi- Parametric MRI- ( See VIDEO below these slides) Robert Princenthal, M.D., Rolling Oaks Radiology, Thousand Oaks, CA.

Posted in Biopsy, Diagnosis, Imaging, MRI, Treatments for Prostate Cancer | Tagged , , , , | Leave a comment